Cargando…

Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer

OBJECTIVE: Bladder cancer contributes to a serious disease burden in clinical settings. The characteristics and prognosis of patients with muscle-invasive bladder cancer (MIBC) and non-muscle-invasive bladder cancer (NMIBC) are distinctly different. The study aims to figure out the respective role o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shun, Wang, Cheng, Xia, Weimin, Duan, Huangqi, Qian, Subo, Shen, Haibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627284/
https://www.ncbi.nlm.nih.gov/pubmed/34849009
http://dx.doi.org/10.2147/IJGM.S339996
_version_ 1784606821696143360
author Zhang, Shun
Wang, Cheng
Xia, Weimin
Duan, Huangqi
Qian, Subo
Shen, Haibo
author_facet Zhang, Shun
Wang, Cheng
Xia, Weimin
Duan, Huangqi
Qian, Subo
Shen, Haibo
author_sort Zhang, Shun
collection PubMed
description OBJECTIVE: Bladder cancer contributes to a serious disease burden in clinical settings. The characteristics and prognosis of patients with muscle-invasive bladder cancer (MIBC) and non-muscle-invasive bladder cancer (NMIBC) are distinctly different. The study aims to figure out the respective role of ferroptosis in MIBC and NMIBC and to construct ferroptosis-related gene signatures that could predict patients’ prognoses. METHODS: A total of 608 MIBC and 414 NMIBC RNA-seq transcriptome data with intact clinical and follow-up information were downloaded from The Cancer Genome Atlas (TCGA), ArrayExpress, and Gene expression omnibus (GEO) database. Ferroptosis-related multigene prognostic models were constructed and externally validated, respectively, in MIBC and NMIBC. Further functional enrichment analyses were also performed to explicate the underlying mechanisms and the differences between the two bladder cancer subtypes. RESULTS: In MIBC, a 7-gene signature for prognostic prediction was constructed. Patients were then divided into high-risk and low-risk groups according to the risk scores calculated by the 7-gene prognostic model. Patients in the high-risk group presented an impaired OS when compared with patients in the low-risk group both in the training cohort and validation cohort. Further functional analyses revealed distinctly different immune statuses between the two risk-stratification groups, speculating that exhausted immune cell function was a cause of the worst OS in the high-risk group. In NMIBC, 6 ferroptosis-related genes were identified that were significantly correlated with recurrence-free survival (RFS). Similarly, a 6-gene prognostic model was constructed and verified as an independent prognostic predictor for RFS. Functional analyses revealed significant differences in the expressions of nuclear division genes between the high-risk group and low-risk group. CONCLUSION: Two novel ferroptosis-related multigene prognostic models for, respectively, predicting OS in MIBC and RFS in NMIBC were identified in this study, which indicated ferroptosis played vital roles in the oncogenesis and development of MIBC and NMIBC.
format Online
Article
Text
id pubmed-8627284
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-86272842021-11-29 Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer Zhang, Shun Wang, Cheng Xia, Weimin Duan, Huangqi Qian, Subo Shen, Haibo Int J Gen Med Original Research OBJECTIVE: Bladder cancer contributes to a serious disease burden in clinical settings. The characteristics and prognosis of patients with muscle-invasive bladder cancer (MIBC) and non-muscle-invasive bladder cancer (NMIBC) are distinctly different. The study aims to figure out the respective role of ferroptosis in MIBC and NMIBC and to construct ferroptosis-related gene signatures that could predict patients’ prognoses. METHODS: A total of 608 MIBC and 414 NMIBC RNA-seq transcriptome data with intact clinical and follow-up information were downloaded from The Cancer Genome Atlas (TCGA), ArrayExpress, and Gene expression omnibus (GEO) database. Ferroptosis-related multigene prognostic models were constructed and externally validated, respectively, in MIBC and NMIBC. Further functional enrichment analyses were also performed to explicate the underlying mechanisms and the differences between the two bladder cancer subtypes. RESULTS: In MIBC, a 7-gene signature for prognostic prediction was constructed. Patients were then divided into high-risk and low-risk groups according to the risk scores calculated by the 7-gene prognostic model. Patients in the high-risk group presented an impaired OS when compared with patients in the low-risk group both in the training cohort and validation cohort. Further functional analyses revealed distinctly different immune statuses between the two risk-stratification groups, speculating that exhausted immune cell function was a cause of the worst OS in the high-risk group. In NMIBC, 6 ferroptosis-related genes were identified that were significantly correlated with recurrence-free survival (RFS). Similarly, a 6-gene prognostic model was constructed and verified as an independent prognostic predictor for RFS. Functional analyses revealed significant differences in the expressions of nuclear division genes between the high-risk group and low-risk group. CONCLUSION: Two novel ferroptosis-related multigene prognostic models for, respectively, predicting OS in MIBC and RFS in NMIBC were identified in this study, which indicated ferroptosis played vital roles in the oncogenesis and development of MIBC and NMIBC. Dove 2021-11-23 /pmc/articles/PMC8627284/ /pubmed/34849009 http://dx.doi.org/10.2147/IJGM.S339996 Text en © 2021 Zhang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zhang, Shun
Wang, Cheng
Xia, Weimin
Duan, Huangqi
Qian, Subo
Shen, Haibo
Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer
title Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer
title_full Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer
title_fullStr Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer
title_full_unstemmed Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer
title_short Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer
title_sort novel ferroptosis-related multigene prognostic models for patients with bladder cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627284/
https://www.ncbi.nlm.nih.gov/pubmed/34849009
http://dx.doi.org/10.2147/IJGM.S339996
work_keys_str_mv AT zhangshun novelferroptosisrelatedmultigeneprognosticmodelsforpatientswithbladdercancer
AT wangcheng novelferroptosisrelatedmultigeneprognosticmodelsforpatientswithbladdercancer
AT xiaweimin novelferroptosisrelatedmultigeneprognosticmodelsforpatientswithbladdercancer
AT duanhuangqi novelferroptosisrelatedmultigeneprognosticmodelsforpatientswithbladdercancer
AT qiansubo novelferroptosisrelatedmultigeneprognosticmodelsforpatientswithbladdercancer
AT shenhaibo novelferroptosisrelatedmultigeneprognosticmodelsforpatientswithbladdercancer